Clinical trial Recruiting at 1 site Interventional Ages 18 and up

PENG block plus local infiltration analgesia for anterior-approach hip replacement

Official title: PENG 360°: PENG Block + LIA Nella Endoprotesi di Anca.

Run by ASST Gaetano Pini-CTO · NCT07239817 · Data updated 2026-11-12

This test sees if a motor-sparing PENG block combined with local infiltration around the hip controls pain as well as spinal anesthesia for adults having anterior‑approach hip replacement.

More Pain, Postoperative trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorASST Gaetano Pini-CTO
Academic / other
Locations1 site (Milan)
StatusRecruiting
StartedDecember 9, 2025
Main results expectedFebruary 28, 2027
Study endsFebruary 28, 2027
Registry record updatedSeptember 22, 2026
Trial IDNCT07239817 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) scheduled for hip endoprosthesis for a femoral fracture via the anterior surgical approach who can give informed consent and have no contraindications to local anesthetics.

Probably not a fit

Patients with prior major surgery or an existing prosthesis on the same hip, known allergy to local anesthetics, infection at the planned injection site, ASA class > IV, or those who require intraoperative opioids or conversion to general anesthesia are excluded and unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized comparison assigns adults having anterior‑approach hip endoprosthesis to either an ultrasound‑guided anterior/posterior PENG block combined with local infiltration analgesia (LIA) or to standard spinal anesthesia. The PENG+LIA arm uses targeted pericapsular sensory injections (A‑PENG and PONG) and a 360° LIA protocol intended to provide surgical anesthesia without major motor blockade. Primary outcomes include pain scores over the first 48 hours and time to first mobilization, with secondary outcomes capturing nausea and other side effects. The aim is to determine whether pain control is similar while allowing earlier leg movement and rehabilitation.

Why it matters

Potential benefit: If successful, this approach could provide comparable pain relief with less leg weakness, enabling earlier walking and potentially fewer anesthesia‑related side effects.

How similar studies have gone: Smaller studies and case series of PENG and other motor‑sparing regional techniques have reported promising analgesia and preserved motor function, but randomized comparisons of PENG+LIA versus spinal anesthesia are still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Provision of signed and dated informed consent form.
* Scheduled for hip endoprosthesis surgery for femoral fracture with an anterior, lateral or posterolateral approach (any approach).
* Age 18 years or older.
* Willing and able to comply with the study protocol.

Exclusion Criteria:

* Failure to provide informed consent.
* Age less than 18 years.
* Known allergy to local anesthetics or other medications used in the protocol.
* Presence of infection at the planned injection site.
* Pre-existing hip prosthesis or prior major surgery on the same hip (e.g., revision surgery).
* ASA physical status class \> IV.
* Administration of intraoperative opiates or conversion to general anesthesia.

Where it's running

  • Gaetano Pini-CTO
    Milan, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.